Evercore ISI Trims DENTSPLY SIRONA (NASDAQ:XRAY) Target Price to $27.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target decreased by Evercore ISI from $28.00 to $27.00 in a report issued on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical instruments supplier’s stock.

Other analysts have also recently issued reports about the company. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a research note on Friday, May 3rd. Robert W. Baird cut their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research report on Friday, May 3rd. The Goldman Sachs Group cut their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating on the stock in a research report on Monday, May 6th. Barrington Research reiterated an outperform rating and set a $38.00 target price on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Finally, StockNews.com cut DENTSPLY SIRONA from a buy rating to a hold rating in a research report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $34.33.

DENTSPLY SIRONA Stock Down 0.7 %

DENTSPLY SIRONA stock opened at $25.53 on Tuesday. DENTSPLY SIRONA has a 1-year low of $23.94 and a 1-year high of $41.65. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The stock has a market cap of $5.30 billion, a PE ratio of -58.02, a P/E/G ratio of 1.09 and a beta of 1.01. The stock’s fifty day moving average is $26.66 and its two-hundred day moving average is $31.06.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same period last year, the firm earned $0.39 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. On average, sell-side analysts expect that DENTSPLY SIRONA will post 2.02 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date of this dividend was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction that occurred on Friday, May 31st. The shares were purchased at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the acquisition, the director now directly owns 58,374 shares in the company, valued at approximately $1,631,553.30. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in XRAY. VisionPoint Advisory Group LLC boosted its stake in shares of DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares in the last quarter. Principal Securities Inc. purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Headlands Technologies LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $30,000. Parkside Financial Bank & Trust boosted its stake in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $47,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.